125 related articles for article (PubMed ID: 26355551)
1. Asparagine Synthetase Expression and Phase I Study With L-Asparaginase Encapsulated in Red Blood Cells in Patients With Pancreatic Adenocarcinoma.
Bachet JB; Gay F; Maréchal R; Galais MP; Adenis A; MsC DS; Cros J; Demetter P; Svrcek M; Bardier-Dupas A; Emile JF; Hammel P; Ebenezer C; Berlier W; Godfrin Y; André T
Pancreas; 2015 Oct; 44(7):1141-7. PubMed ID: 26355551
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic tumor sensitivity to plasma L-asparagine starvation.
Dufour E; Gay F; Aguera K; Scoazec JY; Horand F; Lorenzi PL; Godfrin Y
Pancreas; 2012 Aug; 41(6):940-8. PubMed ID: 22513289
[TBL] [Abstract][Full Text] [Related]
3. Low expression of asparagine synthetase in lymphoid blasts precludes its role in sensitivity to L-asparaginase.
Hermanova I; Zaliova M; Trka J; Starkova J
Exp Hematol; 2012 Aug; 40(8):657-65. PubMed ID: 22542578
[TBL] [Abstract][Full Text] [Related]
4. l-asparaginase loaded red blood cells in refractory or relapsing acute lymphoblastic leukaemia in children and adults: results of the GRASPALL 2005-01 randomized trial.
Domenech C; Thomas X; Chabaud S; Baruchel A; Gueyffier F; Mazingue F; Auvrignon A; Corm S; Dombret H; Chevallier P; Galambrun C; Huguet F; Legrand F; Mechinaud F; Vey N; Philip I; Liens D; Godfrin Y; Rigal D; Bertrand Y
Br J Haematol; 2011 Apr; 153(1):58-65. PubMed ID: 21332712
[TBL] [Abstract][Full Text] [Related]
5. S100A2 is a predictive biomarker of adjuvant therapy benefit in pancreatic adenocarcinoma.
Bachet JB; Maréchal R; Demetter P; Bonnetain F; Cros J; Svrcek M; Bardier-Dupas A; Hammel P; Sauvanet A; Louvet C; Paye F; Vaillant JC; André T; Closset J; Salmon I; Emile JF; Van Laethem JL
Eur J Cancer; 2013 Aug; 49(12):2643-53. PubMed ID: 23726265
[TBL] [Abstract][Full Text] [Related]
6. Asparagine synthetase expression and its potential prognostic value in patients with NK/T cell lymphoma.
Li Y; Zhang X; Hu T; Han L; Li R; Wen J; Zhang M
Oncol Rep; 2014 Aug; 32(2):853-9. PubMed ID: 24913732
[TBL] [Abstract][Full Text] [Related]
7. Phase II study of L-asparaginase in the treatment of pancreatic carcinoma.
Lessner HE; Valenstein S; Kaplan R; DeSimone P; Yunis A
Cancer Treat Rep; 1980; 64(12):1359-61. PubMed ID: 7471124
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic Silencing Affects l-Asparaginase Sensitivity and Predicts Outcome in T-ALL.
Touzart A; Lengliné E; Latiri M; Belhocine M; Smith C; Thomas X; Spicuglia S; Puthier D; Pflumio F; Leguay T; Graux C; Chalandon Y; Huguet F; Leprêtre S; Ifrah N; Dombret H; Macintyre E; Hunault M; Boissel N; Asnafi V
Clin Cancer Res; 2019 Apr; 25(8):2483-2493. PubMed ID: 30659025
[TBL] [Abstract][Full Text] [Related]
9. A phase I and pharmacodynamic evaluation of polyethylene glycol-conjugated L-asparaginase in patients with advanced solid tumors.
Taylor CW; Dorr RT; Fanta P; Hersh EM; Salmon SE
Cancer Chemother Pharmacol; 2001; 47(1):83-8. PubMed ID: 11221967
[TBL] [Abstract][Full Text] [Related]
10. [Relationship between asparagine synthetase expression level and cell sensitivity to L-asparaginase in human leukemic cell lines].
Li BS; He YY; Luo CY; Jiang H; Shen SH; Jiang LM; Zhang B; Gu LJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):559-63. PubMed ID: 20561401
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase.
Iwamoto S; Mihara K; Downing JR; Pui CH; Campana D
J Clin Invest; 2007 Apr; 117(4):1049-57. PubMed ID: 17380207
[TBL] [Abstract][Full Text] [Related]
12. Asparagine synthetase as a causal, predictive biomarker for L-asparaginase activity in ovarian cancer cells.
Lorenzi PL; Reinhold WC; Rudelius M; Gunsior M; Shankavaram U; Bussey KJ; Scherf U; Eichler GS; Martin SE; Chin K; Gray JW; Kohn EC; Horak ID; Von Hoff DD; Raffeld M; Goldsmith PK; Caplen NJ; Weinstein JN
Mol Cancer Ther; 2006 Nov; 5(11):2613-23. PubMed ID: 17088436
[TBL] [Abstract][Full Text] [Related]
13. Targeting Asparagine Synthetase in Tumorgenicity Using Patient-Derived Tumor-Initiating Cells.
Nishikawa G; Kawada K; Hanada K; Maekawa H; Itatani Y; Miyoshi H; Taketo MM; Obama K
Cells; 2022 Oct; 11(20):. PubMed ID: 36291140
[TBL] [Abstract][Full Text] [Related]
14. Identification of a cytogenetic and molecular subgroup of acute myeloid leukemias showing sensitivity to L-Asparaginase.
Bertuccio SN; Serravalle S; Astolfi A; Lonetti A; Indio V; Leszl A; Pession A; Melchionda F
Oncotarget; 2017 Dec; 8(66):109915-109923. PubMed ID: 29299118
[TBL] [Abstract][Full Text] [Related]
15. Second-Line Treatment in Pancreatic Cancer Patients: Who Profits?--Results From the CONKO Study Group.
Sinn M; Dälken L; Striefler JK; Bischoff S; Schweitzer N; Pelzer U; Dörken B; Riess H; Stieler JM
Pancreas; 2016 Apr; 45(4):601-5. PubMed ID: 26646276
[TBL] [Abstract][Full Text] [Related]
16. A Phase 2 study of L-asparaginase encapsulated in erythrocytes in elderly patients with Philadelphia chromosome negative acute lymphoblastic leukemia: The GRASPALL/GRAALL-SA2-2008 study.
Hunault-Berger M; Leguay T; Huguet F; Leprêtre S; Deconinck E; Ojeda-Uribe M; Bonmati C; Escoffre-Barbe M; Bories P; Himberlin C; Chevallier P; Rousselot P; Reman O; Boulland ML; Lissandre S; Turlure P; Bouscary D; Sanhes L; Legrand O; Lafage-Pochitaloff M; Béné MC; Liens D; Godfrin Y; Ifrah N; Dombret H;
Am J Hematol; 2015 Sep; 90(9):811-8. PubMed ID: 26094614
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of asparagine synthetase fails to avert cell cycle arrest induced by L-asparaginase in TEL/AML1-positive leukaemic cells.
Krejci O; Starkova J; Otova B; Madzo J; Kalinova M; Hrusak O; Trka J
Leukemia; 2004 Mar; 18(3):434-41. PubMed ID: 14724653
[TBL] [Abstract][Full Text] [Related]
18. Expression of asparagine synthetase predicts in vitro response to L-asparaginase in canine lymphoid cell lines.
Smallwood TL; Small GW; Suter SE; Richards KL
Leuk Lymphoma; 2014 Jun; 55(6):1357-65. PubMed ID: 24033105
[TBL] [Abstract][Full Text] [Related]
19. FDA drug approval summary: pegaspargase (oncaspar) for the first-line treatment of children with acute lymphoblastic leukemia (ALL).
Dinndorf PA; Gootenberg J; Cohen MH; Keegan P; Pazdur R
Oncologist; 2007 Aug; 12(8):991-8. PubMed ID: 17766659
[TBL] [Abstract][Full Text] [Related]
20. Asparagine synthetase is a predictive biomarker of L-asparaginase activity in ovarian cancer cell lines.
Lorenzi PL; Llamas J; Gunsior M; Ozbun L; Reinhold WC; Varma S; Ji H; Kim H; Hutchinson AA; Kohn EC; Goldsmith PK; Birrer MJ; Weinstein JN
Mol Cancer Ther; 2008 Oct; 7(10):3123-8. PubMed ID: 18852115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]